Industries > Pharma > Next-Generation Sequencing Market Report 2019-2029

Next-Generation Sequencing Market Report 2019-2029

Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others

PAGES: 189
PRODUCT CODE: PHA0379

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0379 Categories: , Tag:

The next generation sequencing market is estimated to have reached $7bn in 2018. Both genetic screening and diagnostic segments dominated the next generation sequencing market in 2018.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Application:
• Drug Discovery
• Genetic Screening
• Diagnostics
• Personalized Medicine
• Agriculture and Animal Research
• Infectious Diseases
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Technology:
• Whole-Genome Sewuencing
• Targeted Re-Sequencing
• Exome Sequencing
• RNA Seq
• Chip Seq
• De Novo Sequencing
• Methyl Seq
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Product:
• Instruments
• Reagents & Consumables
• Services

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by End User:
• Hospital & Healthcare Institution
• Academics
• Biotechnology
• Pharmaceutical
• Others

• Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Regional and National Market:

• North America
• US
• Canada

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Europe
• Germany
• The UK
• Italy
• France
• Spain
• Russia
• Rest of Europe

• Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• South Korea
• Rest of Asia-Pacific

• MEA
• GCC Countries
• Israel
• Rest of Middle East

• Africa
• South Africa
• Central Africa
• North Africa

Each regional market is further segmented by submarkets.

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies’ operations:
Agilent Technologies, Inc.
BGI (Beijing Genomics Institute)
Eurofins Scientific
F. Hoffmann-La Roche AG
Illumina, Inc
Macrogen, Inc
Oxford Nanopore Technologies, Ltd
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc

Buy our report today Next-Generation Sequencing Market Forecast 2019-2029: Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Next-Generation Sequencing Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Next-Generation Sequencing Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories